DYB-186

N/A

Report date: 2025/01/26 16:27:10
NME

Base Information

Drug NameDYB-186
Drug Alias NameDYB-186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein A-I stimulants
TargetsApolipoprotein A-I
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDybly Ag
China Registration ClassN/A

Develop Information

Active CompaniesDybly Ag
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A